Literature DB >> 8976958

Accuracy of color Doppler sonography in assessing venous thrombus extension in renal cell carcinoma.

H K Habboub1, M M Abu-Yousef, R D Williams, W A See, G D Schweiger.   

Abstract

OBJECTIVE: Our objective was to evaluate the accuracy of color Doppler sonography for assessing tumor thrombus extension into the renal veins, the inferior vena cava, and the right side of the heart in patients with renal cell carcinoma.
MATERIALS AND METHODS: Over the past 4.5 years, 44 patients with 46 renal cell carcinomas were examined with color Doppler sonography for the presence and extent of tumor thrombus in the renal veins, the inferior vena cava, and the right side of the heart. Examinations were performed after an equivocal CT scan in 34 patients and as a primary imaging technique in 10. Color Doppler sonographic findings were correlated with surgical-pathologic findings or findings from autopsies performed within 3 months of the Doppler study. Seven patients were excluded: two because of poor technical quality caused by body habitus and five because pathologic correlation was performed more than 3 months after the color Doppler sonographic examination. The remaining 39 renal vein and 37 caval Doppler examinations constituted the study material. Criteria used for the diagnosis of tumor thrombus included distention of the renal vein or the inferior vena cava by echogenic material and partial or complete absence of flow detected with color Doppler sonographic examination.
RESULTS: Sixteen of 39 renal veins evaluated had pathology-proven tumor thrombus. Color Doppler sonography was 87% accurate with a sensitivity of 75%, a specificity of 96%, a positive predictive value of 92%, and a negative predictive value of 85%. In two false-positive cases, involvement was limited to intrarenal veins, causing no change in the surgical approach. Five of 37 inferior venae cavae evaluated had proven involvement by tumor thrombus. Color Doppler sonography was 100% accurate in assessing the presence and extent of inferior vena caval involvement by tumor thrombus. Extension into the right atrium and ventricle that was shown by this technique was proven by surgery in one case. The overall accuracy for detecting venous involvement for both the renal veins and the inferior vena cava was 93%, the sensitivity was 81%, and the specificity was 98%.
CONCLUSION: In patients with renal cell carcinoma, color Doppler sonography appears to be fairly accurate in assessing tumor extension into the renal veins, the inferior vena cava, and the right side of the heart. Although CT is the primary imaging technique for staging renal cell carcinoma, color Doppler sonography may be used as a complementary technique for assessing venous extension in patients with an equivocal CT examination.

Entities:  

Mesh:

Year:  1997        PMID: 8976958     DOI: 10.2214/ajr.168.1.8976958

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Authors:  Ricardo A Rendon; Anil Kapoor; Rodney Breau; Michael Leveridge; Andrew Feifer; Peter C Black; Alan So
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

2.  Molecular aspects of renal cell carcinoma: a review.

Authors:  Hari Koul; Jung-Sik Huh; Kyle O Rove; Luiza Crompton; Sweaty Koul; Randall B Meacham; Fernando J Kim
Journal:  Am J Cancer Res       Date:  2010-12-18       Impact factor: 6.166

3.  Contrast enhanced ultrasound of renal masses.

Authors:  Andre Ignee; Bernd Straub; Gudrun Schuessler; Christoph Frank Dietrich
Journal:  World J Radiol       Date:  2010-01-28

Review 4.  Renal Cell Carcinoma Ablation: Preprocedural, Intraprocedural, and Postprocedural Imaging.

Authors:  Winston B Joe; Jessica G Zarzour; Andrew J Gunn
Journal:  Radiol Imaging Cancer       Date:  2019-11-29

Review 5.  Imaging management of incidentally detected small renal masses.

Authors:  V Anik Sahni; Stuart G Silverman
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

6.  CT/MRI in staging renal cell carcinoma.

Authors:  Rodney H Reznek
Journal:  Cancer Imaging       Date:  2004-02-14       Impact factor: 3.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.